Supplementary Figure 4 from Ligand-Dependent Platelet-Derived Growth Factor Receptor (PDGFR)-α Activation Sensitizes Rare Lung Cancer and Sarcoma Cells to PDGFR Kinase Inhibitors
Ultan McDermott(AstraZeneca (United Kingdom)), Jeffrey Settleman(Harvard University), Randy Milano(Harvard University), Laury Lucien(Harvard University), Rachel Y. Ames(Rapt Therapeutics (United States)), Brian W. Brannigan(Harvard University), A. John Iafrate(Peter MacCallum Cancer Centre), Shyamala Maheswaran(Massachusetts General Hospital), Hannah Stubbs(Harvard University), Sreenath V. Sharma(Harvard University), Kaitlin McCutcheon(Harvard University), Patricia Greninger(Harvard University), Xiaojun Ma(Advanced Cell Diagnostics (United States)), Diana Lee, Angela Tam(Canada's Michael Smith Genome Sciences Centre), Daniel A. Haber(Howard Hughes Medical Institute), Lindsey E. Ulkus(Harvard University), Mark G. Erlander
Cited by 0